|
IPM
|
0.03
|
0.09
|
0.01–0.7
|
204
|
|
Cognitive impairment to dementia
|
0.001
|
9.5
|
2.7–33.5
|
68
|
|
Nursing home resident
|
0.001
|
8.1
|
2.3–28.3
|
77
|
|
Intensive care stay
|
0.012
|
4.8
|
1.4–16.0
|
85
|
|
Anemia
|
0.17
|
2.4
|
0.7–8.1
|
174
|
|
BMI ≤20 kg/m2
|
0.4
|
2.5
|
0.3–21.5
|
19 (m162)
|
|
COPD
|
0.2
|
2.9
|
0.6–14.1
|
30
|
|
Diabetes mellitus
|
0.2
|
2.3
|
0.7–7.8
|
139
|
|
Infection requiring antibiotics
|
0.003
|
6.6
|
1.9–23.2
|
89
|
|
Fall in hospital
|
0.2
|
2.8
|
0.5–13.5
|
31
|
|
Men
|
0.2
|
2.0
|
0.6–6.8
|
119
|
|
Parkinson’s disease
|
0.05
|
4.9
|
1.0–24.5
|
19
|
|
Chronic hemodialysis
|
0.3
|
3.2
|
0.4–26.8
|
13
|
|
Atrial fibrillation
|
0.05
|
12.0
|
1.0–143.9
|
13 (m1324)
|
|
Antipsychotics
|
0.001
|
12.3
|
3.5–43.5
|
56
|
|
NSAIDs
|
0.3
|
2.0
|
0.5–7.9
|
64
|
|
Paracetamol / Metamizole
|
0.2
|
3.0
|
0.6–13.9
|
246
|
|
Muscle relaxants
|
0.2
|
4.8
|
0.5–42.2
|
9
|
|
Digitalis
|
0.4
|
2.0
|
0.4–9.7
|
41
|
|
Corticosteroids
|
0.3
|
2.3
|
0.5–11.3
|
36
|
|
Antifungal drugs
|
0.09
|
6.5
|
0.7–58.7
|
7
|
|
Memantine
|
0.4
|
2.5
|
0.3–20.8
|
16
|
|
Antiparkinsonian drugs
|
0.03
|
6.0
|
1.2–30.5
|
16
|
|
Xanthines
|
0.002
|
17.2
|
2.9–101.0
|
7
|
|
Fall risk scale according to Huhn
| | | |
394 (m110)
|
|
temporarily disoriented
|
0.006
|
6.7
|
1.7–26.1
|
41
|
|
permanently disoriented
|
0.1
|
3.6
|
0.7–19.0
|
37
|
|
occasional alcohol consumption
|
0.1
|
2.9
|
0.7–11.4
|
46
|
|
restrictions in mobility
|
0.2
|
3.7
|
0.5–29.5
|
136
|
|
bladder catheter / enterostoma
|
0.1
|
3.6
|
0.6–19.9
|
90
|
|
bladder / stool incontinent
|
0.2
|
3.9
|
0.5–28.9
|
41
|
